检索结果-南通市图书馆

chinese national clinical practice {3.s on the prevention,diagnosis,and treatment of early gastric cancer

chinese Medical journal 2024年第8期137卷 887-908页

作者： Peng Li Ziyu Li Enqiang Linghu Jiafu Ji Society of Digestive Endoscopy of the chinese Medical Association Colorectal Surgery Group of the chinese Medical Association chinese Association of Gastroenterologists&Hepatologists National {3. Research Center for Digestive Diseases chinese Medical journal {3. practice guideline collaborative Department of Gastroenterology Beijing Friendship HospitalCapital Medical UniversityNational Clinical Research Center for Digestive DiseaseBeijing 100050China Department of Gastrointestinal Surgery Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education)Peking University Cancer Hospital and InstituteBeijing 100142China Department of Gastroenterology and Hepatology the First Medical CenterChinese People’s Liberation Army General HospitalBeijing 100853China 不详

Background:Gastric cancer is one of the most common malignant tumors in the digestive system in *** comprehensive practice guidelines for early gastric cancer in China are currently ***,we created the chinese national {3. practice guideline for the prevention,diagnosis,and treatment of early gastric ***:This {3. practice guideline(CPG)was developed in accordance with the World Health Organization’s recommended process and with the Grading of Recommendations Assessment,Development,and Evaluation(GRADE)in assessing evidence *** used the Evidence to Decision framework to formulate {3. recommendations to minimize bias and increase transparency in the CPG development *** used the Reporting Items for practice guidelines in HealThcare(RIGHT)statement and the Appraisal of guidelines for Research and Evaluation II(AGREE II)as reporting and conduct guidelines to ensure completeness and transparency of the ***:This CPG contains 40 recommendations regarding the prevention,screening,diagnosis,treatment,and follow-up of early gastric cancer based on available {3. studies and *** provide recommendations for the timing of Helicobacter pylori eradication,screening populations for early gastric cancer,indications for endoscopic resection and surgical gastrectomy,follow-up interval after treatment,and other ***:This CPG can lead to optimum care for patients and populations by providing up-to-date medical *** intend this CPG for widespread adoption to increase the standard of prevention,screening,diagnosis,treatment,and follow-up of early gastric cancer;thereby,contributing to improving national health care and patient quality of life.

关键词： Early gastric cancer Prevention Screening Diagnosis Treatment Follow-up

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

chinese national clinical practice {3.s on prevention, diagnosis and treatment of early colorectal cancer

引用

中华医学杂志(英文版) 2024年第17期137卷 2024 Aug 6页

作者： Li Jingnan Yao Hongwei Lu Yun Zhang Shutian Zhang Zhongtao Society of Digestive Endoscopy of the chinese Medical Association Colorectal Surgery Group of the chinese Medical Association chinese Association of Gastroenterologist & Hepatologist National {3. Research Center for Digestive Diseases chinese Medical journal {3. Practie guideline collaborative Department of Gastroenterology Peking Union Medical College Hospital Chinese Academy of Medical Sciences Peking Union Medical College Beijing China Department of General Surgery Beijing Friendship Hospital Capital Medical University National Clinical Research Center for Digestive Diseases Beijing China Department of General Surgery The Affiliated Hospital of Qingdao University Qingdao Shandong China Department of Gastroenterology Beijing Friendship Hospital Capital Medical University National Clinical Research Center for Digestive Disease Beijing China

Background: The incidence and mortality of colorectal cancer (CRC) in China are increasing in recent years. The clarified pathogenesis and detectable precancerous lesions of CRC make it possible to prevent, screen, and diagnose CRC at an early stage. With the development of endoscopic and surgical techniques, the choice of treatment for early CRC is also worth further discussion, and accordingly, a standard follow-up program after treatment needs to be ***: This clinical practice guideline (CPG) was developed following the recommended process of the World Health Organization, adopting Grading of Recommendations Assessment, Development and Evaluation (GRADE) in assessing evidence quality, and using the Evidence to Decision framework to formulate clinical recommendations, thereby minimizing bias and increasing transparency of the CPG development process. We used the Reporting Items for practice guidelines in HealThcare (RIGHT) statement and Appraisal of guidelines for Research and Evaluation II (AGREE II) as reporting and conduct guides to ensure the guideline’s completeness and ***: This CPG comprises 46 recommendations concerning prevention, screening, diagnosis, treatment, and surveillance of CRC. In these recommendations, we have indicated protective and risk factors for CRC and made recommendations for chemoprevention. We proposed a suitable screening program for CRC based on the chinese context. We also provided normative statements for the diagnosis, treatment, and surveillance of CRC based on existing clinical evidence and ***: The 46 recommendations in this CPG are formed with consideration for stakeholders’ values and preferences, feasibility, and acceptability. Recommendations are generalizable to resource-limited settings with similar CRC epidemiology pattern as China.

关键词： Colorectal cancer Early detection of cancer Prevention Screening Diagnosis Treatment Follow-up guideline

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

chinese national clinical practice {3. on diagnosis and treatment of biliary tract cancers

引用

中华医学杂志(英文版) 2024年第19期137卷 2024 Sep 4页

作者： Wang Xu’an Bai Yongrui Chai Ningli Li Yexiong Linghu Enqiang Wang Liwei Liu Yingbin Society of Hepato-pancreatobiliary Surgery of chinese Research Hospital Association Society of Digestive Endoscopy of the chinese Medical Association chinese Medical {3. clinical practice guideline collaborative Department of Biliary and Pancreatic Surgery Renji Hospital Shanghai Jiao Tong University School of Medicine State Key Laboratory of Systems Medicine for Cancers Shanghai Cancer Institute Shanghai Key Laboratory for Cancer Systems Regulation and clinical Translation Shanghai China Department of Radiation Oncology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China Department of Gastroenterology and Hepatology the First Medical Center Chinese People’s Liberation Army General Hospital Beijing China State Key Laboratory of Molecular Oncology and Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing China State Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Department of Oncology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Background: Biliary tract carcinoma (BTC) is relatively rare and comprises a spectrum of invasive tumors arising from the biliary tree. The prognosis is extremely poor. The incidence of BTC is relatively high in Asian countries, and a high number of cases are diagnosed annually in China owing to the large population. Therefore, it is necessary to clarify the epidemiology and high-risk factors for BTC in China. The signs associated with BTC are complex, often require collaborative treatment from surgeons, endoscopists, oncologists, and radiation therapists. Thus, it is necessary to develop a comprehensive chinese guideline for ***: This {3. practice guideline (CPG) was developed following the process recommended by the World Health Organization. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess the certainty of evidence and make recommendations. The full CPG report was reviewed by external guideline methodologists and clinicians with no direct involvement in the development of this CPG. Two guideline reporting checklists have been adhered to: Appraisal of guidelines for Research and Evaluation (AGREE) and Reporting Items for practice guidelines in Healthcare (RIGHT).Results: The guideline development group, which comprised 85 multidisciplinary {3. experts across China. After a controversies conference, 17 {3. questions concerning the prevention, diagnosis, and treatment of BTC were proposed. Additionally, detailed descriptions of the surgical principles, perioperative management, chemotherapy, immunotherapy, targeted therapy, radiotherapy, and endoscopic management were ***: The guideline development group created a comprehensive chinese guideline for the diagnosis and treatment of BTC, covering various aspects of epidemiology, diagnosis, and treatment. The 17 {3. questions have important reference value for the management of BTC.

关键词： Biliary tract carcinoma Etiology Diagnosis Treatment Surgery

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

美罗培南治疗新生儿脓毒症的临床实践指南(2024年版)

引用

中国当代儿科杂志 2024年第2期26卷 107-117页

作者：《美罗培南治疗新生儿脓毒症的临床实践指南》制订组北京大学第三医院《中国当代儿科杂志》编辑部童笑梅周文浩杨克虎周鹏翔邢燕不详北京大学第三医院儿科国家儿童医学中心/复旦大学附属儿科医院新生儿科兰州大学基础医学院循证医学中心/世界卫生组织指南实施与知识转化合作中心/甘肃省医学指南行业技术中心北京大学第三医院药剂科/北京大学医学部药物评价中心

美罗培南是新生儿脓毒症治疗中使用最为广泛的特殊级别抗菌药物之一,但其不合理应用导致细菌多重耐药问题日益严峻。该指南遵循规范的制订方法与流程,针对9个临床问题形成了12条推荐意见,内容涵盖新生儿美罗培南的使用时机、推荐剂量、... 详细信息

美罗培南是新生儿脓毒症治疗中使用最为广泛的特殊级别抗菌药物之一,但其不合理应用导致细菌多重耐药问题日益严峻。该指南遵循规范的制订方法与流程,针对9个临床问题形成了12条推荐意见,内容涵盖新生儿美罗培南的使用时机、推荐剂量、延长输注、监测与评估、抗菌药物调整方案、治疗疗程以及碳青霉烯耐药肠杆菌目细菌感染的治疗策略,以期为美罗培南在新生儿脓毒症患儿中的合理使用提供循证证据与用药建议。

关键词：美罗培南脓毒症指南新生儿

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

2023.chinese national clinical practice {3. on diagnosis and management of ulcerative colitis

引用

中华医学杂志(英文版) 2024年第14期137卷 1642-1646页

作者： Inflammatory Bowel Disease Group, chinese Society of Gastroenterology, chinese Medical Association Inflammatory Bowel Disease Quality Control Center of China Inflammatory Bowel Disease Group Chinese Society of Gastroenterology Chinese Medical Association Inflammatory Bowel Disease Quality Control Center of China

The role of chinese expert consensus in standardization and improvement of the clinical diagnosis and treatment of inflammatory bowel disease (IBD) is self-evident. As clinical and basic research in China becomes standardized under a better understanding of IBD, more data on chinese patients have become available to develop a consensus and guideline. This guideline, collaboratively developed by the IBD Group, chinese Society of Gastroenterology, incorporates the latest international consensus statements, domestic research findings, and practical considerations, as an update based on the 2018 chinese consensus on IBD management. The IBD guideline consists of two parts: ulcerative colitis (UC) and Crohn's disease, and this manuscript presented the UC part. The evidence used in this guideline was collected and analyzed by the standard of guideline, and the contents were organized as problem statements, for clarity. The formulation of this guideline aimed to reflect the latest progress in IBD, providing comprehensive and valuable guidance for the clinical management of IBD.

关键词：

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

注射用多黏菌素的儿童应用临床实践指南

引用

中华传染病杂志 2024年第4期42卷 198-209页

作者：唐琳侯宁金炎靳有鹏蒋进皎陆权张伶俐马小军曾宪涛林丽开翟所迪《注射用多黏菌素的儿童应用临床实践指南》指导委员会《注射用多黏菌素的儿童应用临床实践指南》制订专家组山东第一医科大学附属省立医院药学部济南250021 山东第一医科大学附属省立医院临床医学检验部济南250021 山东第一医科大学附属省立医院小儿重症医学科济南250021 山东第一医科大学附属省立医院重症医学科济南250021 上海交通大学医学院附属儿童医院呼吸科上海200025 四川大学华西第二医院药学部/循证药学中心成都610041 中国医学科学院、北京协和医学院、北京协和医院感染内科北京100730 武汉大学中南医院循证与转化医学中心武汉430071 武汉大学医院管理研究所武汉430071 北京大学第三医院药学部北京100191 不详

由于多重耐药革兰阴性菌检出率的上升, 尤其是耐碳青霉烯类革兰阴性菌感染的增多, 使得多黏菌素在临床应用的需求逐渐增加, 但该药在儿科患者中的应用仍处于探索阶段。为了指导多黏菌素在儿童患者中的合理使用, 召集多位相关领域专家共... 详细信息

由于多重耐药革兰阴性菌检出率的上升, 尤其是耐碳青霉烯类革兰阴性菌感染的增多, 使得多黏菌素在临床应用的需求逐渐增加, 但该药在儿科患者中的应用仍处于探索阶段。为了指导多黏菌素在儿童患者中的合理使用, 召集多位相关领域专家共同制订了本指南, 对多黏菌素类的药物特点进行了阐述, 讨论了其在应用中面临的多个临床问题, 并就其应用条件、特殊用药方法、特殊人群用药和相关不良反应等提出了13.推荐意见。本指南将帮助医护人员在治疗儿童多重耐药革兰阴性菌感染时能更合理地使用多黏菌素, 提高安全性与有效性。

关键词：多黏菌素类儿童感染多重耐药革兰阴性菌指南

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

血液透析滤过质量控制临床实践指南

引用

中华医学杂志 2024年第8期104卷 571-593页

作者：中国医师协会肾脏内科医师分会血液透析滤过质控指南工作组陈香美不详解放军总医院肾脏病医学部肾脏疾病全国重点实验室国家慢性肾病临床医学研究中心国家肾病学专业医疗质量管理与控制中心北京100853

《血液透析滤过质量控制临床实践指南》由血液净化专家组成的编写委员会共同编写,基于目前循证医学证据,同时借鉴和参考了目前国内外相关临床实践指南与专家建议以及《血液净化标准操作规程(2021版)》,重点针对血液透析滤过的适应证、... 详细信息

《血液透析滤过质量控制临床实践指南》由血液净化专家组成的编写委员会共同编写,基于目前循证医学证据,同时借鉴和参考了目前国内外相关临床实践指南与专家建议以及《血液净化标准操作规程(2021版)》,重点针对血液透析滤过的适应证、治疗模式选择、置换液的选择与成分调整、血管通路、抗凝治疗、处方设置以及相关并发症防治等临床及其医疗质量控制问题,提出推荐意见和相关医疗质控指标。目的在于指导我国血液透析滤过的临床实践和临床研究,提高血液透析滤过医疗质量的标准化、规范化和同质化。

关键词：血液透析滤过医疗质量控制临床实践指南

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

clinical practice guidelines for nutritional assessment and monitoring of adult ICU patients in China

引用

journal of Intensive Medicine 2024年第2期4卷 137-159页

作者： Xiangdong Guan Dechang Chen Yuan Xu chinese Society of Critical Care Medicine Department of Critical Care Medicine The First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina Department of Critical Care Medicine Ruijin HospitalShanghai Jiao Tong University School of MedicineShanghaiChina Department of Critical Care Medicine Beijing Tsinghua Changgung HospitalBeijingChina 不详

The chinese Society of Critical Care Medicine(CSCCM)has developed clinical practice {3.s for nutrition assessment and monitoring for patients in adult intensive care units(ICUs)in *** {3. focuses on nutrition evaluation and metabolic monitoring to achieve optimal and personalized nutrition therapy for critically ill *** {3. was developed by experts in critical care medicine and evidence-based medicine methodology and was developed after a thorough review of the system and a summary of relevant trials or studies published from 2000 to July 2023.A total of 18 recommendations were formed and consensus was reached through discussions and reviews by expert groups in critical care medicine,parenteral and enteral nutrition,and *** recommendations are based on currently available evidence and cover several key fields,including screening and assessment,evaluation and assessment of enteral feeding intolerance,metabolic and nutritional measurement and monitoring during nutrition therapy,and organ function evaluation related to nutrition *** question was analyzed according to the Population,Intervention,Comparison,and Outcome(PICO)*** addition,interpretations were provided for four questions that did not reach a consensus but may have potential clinical and research *** plan is to update this nutrition assessment and monitoring {3. using the international {3. update method within 3.5 years.

关键词： Adults Critical illness Intensive care unit Nutriti on Nutriti on assessment and monitoring guideline Recommendations chinese Society of Critical Care Medicine-chinese Medical Association(CSCCM-CMA)

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

chinese guidelines for the Diagnosis and Management of Atrial Fibrillation

引用

Cardiology Discovery 2024年第2期4卷 89-133页

作者：无 Changsheng Ma Shulin Wu Shaowen Liu Yaling Han chinese Society of Cardiology Chinese Medical Association Heart Rhythm Committee of chinese Society of Biomedical Engineering 不详

Atrial fibrillation(AF)is the most common sustained cardiac arrhythmia,significantly impacting patients'quality of life and increasing the risk of death,stroke,heart failure,and *** the past 2 decades,there have been significant breakthroughs in AF risk prediction and screening,stroke prevention,rhythm control,catheter ablation,and integrated *** this period,the scale,quality,and experience of AF management in China have greatly improved,providing a solid foundation for the development of guidelines for the diagnosis and management of *** further promote standardized AF management,and apply new technologies and concepts to clinical practice in a timely and comprehensive manner,the {3. Society of Cardiology of the {3. Medical Association and the Heart Rhythm Committee of the {3. Society of Biomedical Engineering have jointly developed the {3. guidelines for the Diagnosis and Management of Atrial *** guidelines have comprehensively elaborated on various aspects of AF management and proposed the CHA,DS,-VASc-60 stroke risk score based on the characteristics of AF in the Asian *** guidelines have also reevaluated the clinical application of AF screening,emphasized the significance of early rhythm control,and highlighted the central role of catheter ablation in rhythm control.

关键词： Atrial fibrillation Anticoagulation Rhythm control Catheter ablation Integrated management guideline

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

舒巴坦治疗神经外科重症患者鲍曼不动杆菌感染中国专家共识

引用

中国现代神经疾病杂志 2024年第6期24卷 407-424页

作者：中华医学会神经外科学分会中国神经外科重症管理协作组石广志赵经纬左玮徐明胡付品不详首都医科大学附属北京天坛医院重症医学科 100070 中国医学科学院北京协和医学院北京协和医院药剂科复旦大学附属华山医院抗生素研究所

多重耐药或广泛耐药鲍曼不动杆菌感染的神经外科重症患者治疗难度大、病死率高。舒巴坦是治疗多重耐药鲍曼不动杆菌感染的有效药物,具有穿透炎性血脑屏障的优势,适用于神经外科重症患者。近年随着鲍曼不动杆菌对舒巴坦的耐药趋势日益严... 详细信息

多重耐药或广泛耐药鲍曼不动杆菌感染的神经外科重症患者治疗难度大、病死率高。舒巴坦是治疗多重耐药鲍曼不动杆菌感染的有效药物,具有穿透炎性血脑屏障的优势,适用于神经外科重症患者。近年随着鲍曼不动杆菌对舒巴坦的耐药趋势日益严峻,舒巴坦治疗多重耐药或广泛耐药鲍曼不动杆菌感染药物剂量、给药途径、联合方案等缺乏规范化标准。中国神经外科重症管理协作组通过梳理相关循证医学证据并经过反复讨论修改后形成《舒巴坦治疗神经外科重症患者鲍曼不动杆菌感染中国专家共识》,涵盖28条共识建议,为舒巴坦在神经外科重症管理中的应用提供科学、可行的临床指导。

关键词：神经外科手术危重病人医疗鲍氏不动杆菌舒巴克坦诊疗指南

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：